| Completed | A Study of Cebranopadol for the Treatment of Acute Pain After Abdominoplasty Acute Pain | Phase 3 | 2024-09-03 |
| Completed | A Study of Cebranopadol for the Treatment of Acute Pain After Bunionectomy Acute Pain | Phase 3 | 2024-07-18 |
| Completed | A Study to Assess the Abuse Potential of Intranasal Cebranopadol Abuse, Drug | Phase 1 | 2024-06-28 |
| Completed | Cebranopadol Effects on Ventilatory Drive, Central Nervous System (CNS) and Pain. Pain | Phase 1 | 2022-07-29 |
| Completed | Assessment of Abuse Potential of Cebranopadol in Humans Human Abuse Potential | Phase 1 | 2022-03-28 |
| Completed | Amphetamine Extended Release Tablets and Driving Performance in Subjects With Attention Deficit/Hyperactivity ADHD | Phase 2 | 2019-10-01 |
| Completed | Amphetamine Extended-Release Tablets in the Treatment of Adults With ADHD ADHD | Phase 3 | 2019-02-06 |
| Completed | Pharmacokinetic Study of DYANAVEL XR (Amphetamine) Extended-release Oral Suspension, in Children Aged 4 to 5 Y Attention Deficit Hyperactivity Disorder | Phase 4 | 2018-05-07 |
| Completed | Dyanavel® XR Extended-Release Oral Suspension in the Treatment of Children With ADHD: A Laboratory School Stud Attention Deficit Hyperactivity Disorder | Phase 3 | 2017-02-11 |
| Completed | TRI102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD) Attention Deficit Disorder With Hyperactivity | Phase 3 | 2014-03-01 |
| Completed | CORAL XT - Open-label Extension Trial of the CORAL Trial Pain, Neoplasms, Chronic Pain | Phase 3 | 2013-12-18 |
| Terminated | CORAL - Cebranopadol Versus Morphine Prolonged-release in Patients With Chronic Moderate to Severe Pain Relate Pain, Neoplasms, Chronic Pain | Phase 3 | 2013-10-29 |
| Completed | Cebranopadol Efficacy and Safety in Diabetic Patients Suffering From Chronic Pain Caused by Damage to the Nerv Chronic Pain, Diabetic Neuropathies, Diabetes Mellitus | Phase 2 | 2013-09-27 |
| Completed | Evaluation of the Effects of Multiple Doses of Cebranopadol on the Electrical Activity of the Heart in Healthy Prolonged QTc Interval, Pharmacokinetic | Phase 1 | 2013-07-10 |
| Completed | A Clinical Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of Cebranopadol Pharmacokinetic | Phase 1 | 2013-06-20 |
| Completed | A Trial to Evaluate the Abuse Potential of 3 Doses of GRT6005 in Adult Non-dependent Recreational Opioid Users Abuse, Drug | Phase 1 | 2013-04-15 |
| Completed | Safety and Efficacy Study of GRT6005 in Patients With Osteoarthritis (OA) Knee Pain Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee | Phase 2 | 2012-12-04 |
| Completed | Efficacy and Safety of GRT6005 in Patients With Chronic Low Back Pain. Low Back Pain | Phase 2 | 2012-11-01 |
| Completed | Safety and Efficacy of GRT6005 in Pain Due to Diabetic Polyneuropathy Pain, Diabetic Neuropathies | Phase 2 | 2011-05-01 |
| Completed | Assessment of GRT6005 in Painful Osteoarthritis of the Knee Osteoarthritis of the Knee | Phase 2 | 2011-05-01 |
| Completed | Painful Diabetic Polyneuropathy Trial With a New Centrally Acting Analgesic Diabetic Polyneuropathy | Phase 2 | 2009-04-01 |
| Completed | Bunionectomy Trial With GRT6005 Post Operative Pain | Phase 2 | 2009-03-01 |